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Amplified fragment length polymorphism (AFLP) analysis was applied to characterize 33 group I and 37
group II Clostridium botulinum strains. Four restriction enzyme and 30 primer combinations were screened to
tailor the AFLP technique for optimal characterization of C. botulinum. The enzyme combination HindIII and
HpyCH4IV, with primers having one selective nucleotide apiece (Hind-C and Hpy-A), was selected. AFLP
clearly differentiated between C. botulinum groups I and II; group-specific clusters showed <10% similarity
between proteolytic and nonproteolytic C. botulinum strains. In addition, group-specific fragments were de-
tected in both groups. All strains studied were typeable by AFLP, and a total of 42 AFLP types were identified.
Extensive diversity was observed among strains of C. botulinum type E, whereas group I had lower genetic
biodiversity. These results indicate that AFLP is a fast, highly discriminating, and reproducible DNA finger-
printing method with excellent typeability, which, in addition to its suitability for typing at strain level, can be
used for C. botulinum group identification.
Clostridium botulinum is the causative agent of botulism, a
rare disease, but one that is life threatening if left untreated.
Human botulism is mainly caused by C. botulinum strains be-
longing to groups I (proteolytic) and II (nonproteolytic). Clas-
sical food-borne botulism is generally the predominant disease
form. However, in the United States, the most common form
is infant botulism (30). Recently, wound botulism among in-
jecting drug users has also become a problem (26, 27, 29).
Despite its clinical importance, relatively little is known about
the biodiversity of C. botulinum.
DNA-based typing methods, such as pulsed-field gel elec-
trophoresis (PFGE), randomly amplified polymorphic DNA
(RAPD), and ribotyping, have been applied to genotype C.
botulinum (9, 11, 14, 20, 31). However, methods with good
discriminatory power, typeability, and reproducibility are lack-
ing. Although PFGE has proved to be highly discriminating for
typing C. botulinum type E and other clostridia, it is not suit-
able for all clostridial strains due to the degradation of DNA as
a result of extracellular DNase production (9, 15, 19). The use
of RAPD in database creation is hindered by its inadequate
reproducibility (7) and, finally, whereas ribotyping can be fully
automated (Riboprinter), it is more suitable for subtyping bac-
terial species than strain typing because of its lower discrimi-
nating ability (11).
Amplified fragment length polymorphism (AFLP) analysis,
a PCR-based DNA fingerprinting method initially described by
Vos et al. (33), has gained notable interest as a genotyping
method for bacterial species. AFLP analysis consists of three
steps: the purified total DNA is digested with two restriction
enzymes, which is followed by ligation of restriction site-specific
adapters and amplification by PCR of a subset of fragments (33).
AFLP analyses whole-genome DNA for polymorphism, and no
prior sequence information about the target DNA is needed.
Klaassen et al. (18) have also reported that, unlike PFGE, AFLP
analysis is not affected by partial degradation of DNA.
AFLP has been shown to be highly reproducible and dis-
criminative (17, 28). In addition to epidemiological and out-
break studies (1–4, 32), AFLP can also be used for differenti-
ation and identification of bacteria at the species level (6, 16,
17, 28). Although AFLP has been used to characterize related
species, such as Clostridium difficile (18), Clostridium novyi
(25), and Clostridium perfringens (24), it has not, to our knowl-
edge, been used in the molecular typing of C. botulinum.
The aim of the present study was to assess the applicability
of AFLP analysis in characterization of C. botulinum groups I
and II and to study the genetic biodiversity of C. botulinum
types A, B, E, and F. In addition, various enzyme and primer
combinations were screened to tailor the AFLP technique for
optimal characterization of C. botulinum.
MATERIALS AND METHODS
Bacterial strains and PCR. A total of 33 group I and 37 group II C. botulinum
strains from the Culture Collections of the Department of Food and Environ-
mental Hygiene, University of Helsinki, Helsinki, Finland, and the Institute of
Food Research, Norwich, United Kingdom, were studied (Table 1). Multiplex
PCR assay for the simultaneous detection of C. botulinum types A, B, E, and F,
as previously described by Lindstro¨m et al. (22), or PCR assay for separate
detection of type A, B, and E neurotoxin genes in C. botulinum (8) were used to
confirm the serotype of each strain.
DNA extraction. DNA was extracted according to the method of Hyytia¨ et al.
(14), with slight modifications. Strains were grown in a tryptose-peptone-glucose-
yeast medium (Difco Laboratories, Detroit, Mich.) under anaerobic conditions
at 37°C (C. botulinum group I) or 30°C (C. botulinum group II) for 14 to 16 h.
The cells were lysed in TE (10 mM Tris-HCl, 1 mM EDTA) containing lysozyme
(8.3 mg/ml; Sigma, St. Louis, Mo.) and mutanolysin (167 IU/ml; Sigma) at 37°C
for 15 min (C. botulinum group I) or 2 h (C. botulinum group II) with gentle
shaking. Lysis was completed by adding proteinase K (54 g/ml; Finnzymes,
Espoo, Finland), 0.24 M NaCl, 9.5 mM EDTA, and 0.8% (vol/vol) sodium
dodecyl sulfate. The mixture was incubated at 60°C for 1 h with gentle shaking.
Phenol-chloroform-isoamyl alcohol (25:24:1 [vol/vol]) and chloroform–2-penta-
nol (24:1 [vol/vol]) extractions were performed, and DNA was ethanol (95%
[vol/vol]) precipitated and resuspended in TE overnight. RNA was removed by
RNase (475 g/ml; Sigma) at 37°C for 40 min with gentle shaking, followed by
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TABLE 1. C. botulinum strains used in this study
Serotype Group Straina Origin Sourceb PCR result forbotulinum neurotoxin
A I ATCC 25763 Type strain ATCC A
I 69A Human stool DFEH A
I 62A Cow liver DFEH A
I 93/2 (FT 30) NDc IFR A
I RS-3A (Lindroth RS-3A) Pacific red snapper DFEH A
I RS-4A (Lindroth RS-4A) Pacific red snapper DFEH A
I ATCC 3502 (Hall 174A) ND ATCC A
I 93/21 (Eyemouth)* ND IFR A
I 93/33 (NCTC 2012)* Wild duck paste IFR A
I 93/42 (NCTC 3806) Peas IFR A
I 97/13 (CDC 1690) Botulism outbreak IFR A
I BL 81/19 (16037)* Botulism outbreak IFR A
AB I 97/11 (MDa10) Infant IFR A, B
I 97/12 (CDC 588) Botulism outbreak IFR A, B
I 97/15 (NCTC 2916) Corn IFR A, B
B I KS 30/6* Pollen DFEH B
I KS 35/5* Pollen DFEH B
I BL 81/21 (NCTC 3815) Cheese IFR B
I BL 81/25 Asparagus IFR B
I 126B ND DFEH B
I BL81/29 (NCIB 10657) ND IFR B
I BL 87/5B (CDC 15044) Blackberry IFR B
I 93/36 (4B) ND IFR B
I KV40/10 Beeswax DFEH B
I BL 86/7A (BL150) Fish IFR B
I KH57/1 Honey DFEH B
I 93/37 (3807/1) ND IFR B
I ATCC 17841 (1347B) ND ATCC B
I 93/3 (CDC 7827) Human stool IFR B
II 2B (Eklund 2) Marine sediment DFEH B
II 17B (Eklund 17, ATCC 25765) Marine sediment ATCC B
II 2217B (ATCC 17844) ND ATCC B
II BL93/6 (CDC 5900) Human IFR B
II BL 87/7B (5900 A-T-A-3) Human IFR B
II BL 90/4 (Prevot 59) ND IFR B
II BL 93/10 (Kapchunka B2) Fish IFR B
E II K-3 Rainbow trout DFEH E
II K-7 Rainbow trout DFEH E
II K-8 Rainbow trout DFEH E
II K-22 Burbot DFEH E
II K-23 Burbot DFEH E
II K-25 Burbot DFEH E
II K-28 Burbot DFEH E
II K-29 Burbot DFEH E
II K-31 Vendace DFEH E
II K-32 Vendace DFEH E
II K-35 Vendace DFEH E
II K-37 Whitefish DFEH E
II K-44 Rainbow trout DFEH E
II K-45 Rainbow trout DFEH E
II K-46c Rainbow trout roe DFEH E
II K-47 Rainbow trout DFEH E
II K-51c Rainbow trout DFEH E
II K-53c Rainbow trout DFEH E
II K-61c Baltic herring DFEH E
II K-76 Vendace DFEH E
II K-125 Rainbow trout roe DFEH E
II K-126 Salmon DFEH E
II BL 93/7 (CDC 7854) Fish IFR E
II BL 93/8 (CDC 8073) Human IFR E
II 31-2570E ND DFEH E
II BL 81/26 (Beluga) Beluga flipper IFR E
F I 93/26 (ATCC 25764) Crab IFR F
I 93/29 (FT 15, Langeland) ND IFR F
I 93/30 (FT 42, ATCC 25764) ND IFR F
I 93/31 (FT 14, Langeland) ND IFR F
II 202 F (ATCC 23387) Marine sediment ATCC F
II BL 86/32 (Colworth 47) ND IFR F
II BL 86/33 (Colworth 187) ND IFR F
II BL 86/34 (Colworth 195) ND IFR F
a That is, the strain code; original name is in parentheses. , strains used in initial testing.
b ATCC, American Type Culture Collection, Manassas, Va.; DFEH, Culture Collection of the Department of Food and Environmental Hygiene, University of
Helsinki, Helsinki, Finland; IFR, Culture Collection of the Institute of Food Research, Norwich, England.
c ND, no data available.
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the addition of 0.2 M NaCl, chloroform–2-pentanol extraction, and ethanol
precipitation. DNA concentrations were determined with a BioPhotometer (Ep-
pendorf, Hamburg, Germany). DNA was stored at 70°C.
AFLP analysis. In initial testing, four enzyme combinations and 30 primer
couplings (Table 2) were screened by using DNA extracted from C. botulinum
type A (n  3), B (n  2), and E (n  4) strains (Table 1).
An AFLP protocol described previously by Keto-Timonen et al. (17) was used.
Briefly, DNA (400 ng) was digested with either 15 U of HindIII (New England
Biolabs, Beverly, Mass.), 15 U of EcoRI (New England Biolabs), or 15 U of ApaI
(Roche Diagnostics, Basel, Switzerland) and 15 U of HpyCH4IV (New England
Biolabs) or 15 U of MseI (New England Biolabs) in 1One-Phor-All Buffer Plus
(Amersham Biosciences, Buckinghamshire, United Kingdom), bovine serum al-
bumin (0.1 mg/ml), and dithiothreitol (5 mM). Restriction site-specific adapters
(0.4 and 0.04 M; MWG-Biotech AG, Ebersberg, Germany) (Table 3) were
ligated with 1.1 U of T4 DNA ligase (New England Biolabs) in 1 One-Phor-All
Buffer Plus, 200 M ATP, 5 mM dithiothreitol, and bovine serum albumin at 0.1
mg/ml. Samples were stored at 20°C prior to PCR amplification.
Restriction fragments with specific adapters were diluted with sterile, distilled
deionized water (1:10) and amplified by preselective PCR (72°C for 2 min,
followed by 20 cycles of 94°C for 20 s, 56°C for 2 min, and 72°C for 2 min) by
using primers without selective extension in a 20-l reaction mixture containing
4 l of diluted template DNA, 15 l of Amplification Core Mix (Applied
Biosystems, Foster City, Calif.), 25 nM primer specific to rare-cutting restriction
site sequence (MWG-Biotech AG), and 125 nM primer specific to frequent-
cutting restriction site sequence (MWG-Biotech AG) (Table 3). Primer combi-
nations used during subsequent selective amplification are listed in Table 2. The
templates were diluted with sterile, distilled deionized water (1:20) prior to
selective amplification, which was performed in a 10-l reaction mixture con-
taining 1.5 l of diluted template, a 50 nM concentration of IRD800-labeled
primer specific to rare-cutting restriction site sequence (MWG-Biotech AG), a
250 nM concentration of primer specific to frequent-cutting restriction site se-
quence, and 7.5 l of Amplification Core Mix. Treatment consisted of 94°C for
2 min, followed by 1 cycle of 94°C for 20 s, 66°C for 30 s, and 72°C for 2 min,
followed by lowering the annealing temperature by 1°C each cycle to 56°C for 10
cycles, followed in turn by an additional 19 cycles at a 56°C annealing temper-
ature and a final 30-min extension at 60°C. All PCR amplifications were per-
formed with a PTC-200 Peltier thermal cycler (MJ Research, Inc., Waltham,
Mass.).
Selective amplification products (10 l) were mixed with 5 l of stop solution
(LI-COR, Lincoln, Nebr.), denatured at 95°C for 3 min, and placed on ice.
Denatured fragments were separated on a 7% denaturing polyacrylamide gel.
Electrophoresis was performed in 1 Tris-borate-EDTA buffer at 2,000 V, 35
mA, and 40 W at 50°C for 140 min on an automatic DNA sequencer (LI-COR
Global IR2 4200LI-1 Sequencing System; LI-COR). A molecular weight marker
(IRDye800 50- to 700-bp sizing standard; LI-COR) used for gel normalization
was loaded onto every third lane. The level of reproducibility was determined by
using C. botulinum type E strain K-51 as an internal reference, which underwent
each step of the DNA extraction, AFLP analysis, and electrophoresis, thereby
also providing a standard for comparison among different data sets. In addition,
independent duplicate experiments were performed with a total of 38 C. botu-
linum strains representing different serotypes of groups I and II.
AFLP pattern analysis. AFLP patterns were analyzed by using BioNumerics
software 3.0 (Applied Maths, Kortrijk, Belgium). The similarities between nor-
malized AFLP patterns (range, 50 to 350 bp) were calculated with the Pearson
product-moment correlation coefficient (1.0% optimization). Clustering and
construction of dendrograms were performed by using the unweighted pair-
group method with arithmetic averages.
RESULTS
To obtain the optimal distribution of DNA fragments, four
different enzyme combinations were initially tested. The results
TABLE 2. Thirty primer combinations screened during initial
testing to determine optimal primer sets for AFLP typing
of C. botulinum
Primer specific to
rare-cutting
restriction site
sequencea,b
Primer specific to
frequent-cutting
restriction site
sequencea
Eco-C.................................................................................. Hpy-C
Eco-C.................................................................................. Hpy-G
Apa-0.................................................................................. Hpy-A
Apa-0.................................................................................. Hpy-C
Apa-0.................................................................................. Hpy-G
Apa-A................................................................................. Hpy-A
Apa-C ................................................................................. Hpy-0
Apa-C ................................................................................. Hpy-A
Apa-G................................................................................. Hpy-0
Apa-G................................................................................. Hpy-A
Hind-0 ................................................................................ Mse-A
Hind-0 ................................................................................ Mse-C
Hind-0 ................................................................................ Mse-G
Hind-A ............................................................................... Mse-A
Hind-A ............................................................................... Mse-G
Hind-C................................................................................ Mse-A
Hind-C................................................................................ Mse-C
Hind-C................................................................................ Mse-G
Hind-0 ................................................................................ Hpy-A
Hind-0 ................................................................................ Hpy-C
Hind-0 ................................................................................ Hpy-G
Hind-A ............................................................................... Hpy-A
Hind-A ............................................................................... Hpy-C
Hind-A ............................................................................... Hpy-G
Hind-C................................................................................ Hpy-A
Hind-C................................................................................ Hpy-C
Hind-C................................................................................ Hpy-G
Hind-G ............................................................................... Hpy-0
Hind-G ............................................................................... Hpy-A
Hind-G ............................................................................... Hpy-C
a 0, no selective extension; A, C, or G, selective nucleotide at the 3 end of the
primer.
b IRD800-labeled primer.
TABLE 3. Adapter and primer oligonucleotides used in AFLP
Oligonucleotide Sequence(s)
AFLP adapters
Apa adapter...............................................................................................5-TCGTAGACTGCGTACAGGCC-3 and 3-CATCTGACGCATGT-5
Eco adapter ...............................................................................................5-CTCGTAGACTGCGTACC-3 and 3-CTGACGCATGGTTAA-5
Hind adapter .............................................................................................5-CTCGTAGACTGCGTACC-3 and 3-CTGACGCATGGTCGA-5
Hpy adapter...............................................................................................5-GACGATGAGTCCTGAC-3 and 3-TACTCAGGACTGGC-5
Mse adapter...............................................................................................5-GACGATGAGTCCTGAG-3 and 3-CTACTCAGGACTCAT-5
Core sequences of AFLP primersa
Apa primer ................................................................................................5-GACTGCGTACAGGCCC-3
Eco primer.................................................................................................5-GACTGCGTACCAATTC-3
Hind primer...............................................................................................5-GACTGCGTACCAGCTT-3
Hpy primer ................................................................................................5-CGATGAGTCCTGACCGT-3
Mse primer ................................................................................................5-GATGAGTCCTGAGTAA-3
a No selective bases or an adjacent A, C, or G selective nucleotide at the 3 end of the primer.
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obtained with the enzyme combinations HindIII-HpyCH4IV,
EcoRI-HpyCH4IV, or HindIII-MseI yielded high-quality fin-
gerprints, with the HindIII-HpyCH4IV combination having
the most uniform distribution of DNA fragments. The enzyme
coupling ApaI and HpyCH4IV produced only a few fragments
ranging from 50 to 350 bp with the eight primer combinations
tested and thus was unsuitable for AFLP analysis. All primer
combinations containing the Hind primer without selective
extension generated complex banding patterns with numerous
fragments and were deemed inappropriate for numerical anal-
ysis. The selective primers Hind-C and Hpy-A amplified DNA
fragments evenly in the 50- to 350-bp range and consistently
displayed strong signals on gels. In addition, strains described
as identical by PFGE profiling yielded comparable results with
AFLP analysis, and thus primers Hind-C and Hpy-A were
selected for further analysis.
All strains studied were typeable by AFLP. The numerical
analysis of AFLP profiles yielded two distinct group-specific
clusters, with 10% similarity between proteolytic and non-
proteolytic C. botulinum strains (Fig. 1). Strains belonging to
groups I and II clustered together with a similarity value of 45
and 26%, respectively (Fig. 2 and 3). Group II was further
divided into three main clusters. C. botulinum types B and F
clustered together with a similarity value of 62%. The other
two clusters consisted of C. botulinum type E strains.
All group I strains showed the group-specific fragments sizes
of 129, 145, and 336 bp. (Fig. 2). Fragments of 114 and 315 bp
were specific to C. botulinum group II strains (Fig. 3). How-
ever, no C. botulinum species- or serotype-specific fragments
were observed. The PCR analysis of type A, B, E, and F
neurotoxin genes yielded the expected amplification products
and thus confirmed the serotype of each strain included in the
study (Table 1).
In reproducibility testing, the banding pattern, measured
based on fragment sizes, of the internal reference C. botulinum
strain K-51 remained constant during each AFLP analysis. In
addition, independent duplicate experiments of 38 C. botuli-
num strains resulted in identical AFLP banding profiles. De-
spite identical patterns, the internal reference sample showed
89% or higher similarity between different gels due to small
differences in lane or background intensities. The 89% cutoff
value was therefore used to define the AFLP type. By this
criterion, 19 and 23 different AFLP types of C. botulinum
groups I and II, respectively, were identified (Fig. 1).
DISCUSSION
AFLP clearly differentiated between strains of C. botulinum
in groups I and II. This is in accord with previous analyses of
16S rRNA sequences demonstrating that strains of group I C.
botulinum types A, B, and F are phylogenetically distant from
group II C. botulinum types B, E, and F (12, 13). Since group-
specific AFLP fragments were also detected in both groups I
and II, AFLP analysis may be suitable for group identification
as well. Although some serotype-specific subclustering was re-
vealed in both genomic groups, the AFLP method was deemed
unsuitable for definitive serotype determination of C. botuli-
num types A, B, and F. Despite the fact that no serotype-
specific fragments were observed, the two distinct serotype-
specific clusters of C. botulinum type E suggest that AFLP
databases can be used to define serotype E of C. botulinum.
In group II, extensive diversity was observed among strains
of C. botulinum type E, which were divided into two main
clusters, whereas type B and F strains showed highly similar
AFLP profiles and clustered together with a similarity value of
62%. Extensive biodiversity between strains of type E was
demonstrated earlier by PFGE (10, 15). However, no high
similarity of fingerprints among type B and F strains has been
revealed by ribotyping, PFGE, or RAPD, which might be due
to the limited number of nonproteolytic C. botulinum type B
and F strains included in these studies (9, 11, 14). In group I,
FIG. 1. Simplified dendrogram of AFLP profiles of C. botulinum
group I (n  33) and group II (n  37) strains. Clusters containing
AFLP patterns showing89% similarity are shaded. A similarity anal-
ysis was performed by using the Pearson product-moment correlation
coefficient, and clustering was performed by using the unweighted
pair-group method with arithmetic averages. The cophenetic correla-
tion of the dendrogram is 97%.
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both visual examination and numerical analysis of band pat-
terns revealed less diversity than in group II. This is either due
to true lower genetic biodiversity of the strains studied or due
to the selected enzyme and primer combination being more
suitable for discriminating group II strains. However, previous
analyses by using RAPD, repetitive element sequence-based
PCR, and ribotyping have also suggested less genetic variation
among C. botulinum group I strains (11, 14).
A total of 42 different AFLP types were detected, indicating
that AFLP is also an efficient tool for typing at the strain level.
In groups I and II, indistinguishable or highly similar AFLP
profiles were observed in strains that had no known common
origin, a phenomenon also described by Hielm et al. (9) and
Hyytia¨ et al. (15).
AFLP was found to be a highly reproducible method for
DNA fingerprinting of C. botulinum. Since all strains studied
were typeable by AFLP, the extracellular DNase production
detected in some clostridial strains did not appear to affect the
outcome of AFLP analysis. AFLP also proved to be a fast
method; the analysis, including numerical data analysis, could
be done within two working days when the analysis was begun
with pure DNA. Moreover, less hands-on time is required than
with methods such as PFGE, and partial automation enables
high throughput of samples.
FIG. 2. Normalized banding patterns and dendrogram of 33 C. botulinum group I (proteolytic) strains based on AFLP analysis. A similarity
analysis was performed by using the Pearson product-moment correlation coefficient, and clustering was performed by using the unweighted
pair-group method with arithmetic averages. The dashed line shows the cutoff similarity value (89%). Arrows indicate the group-specific fragments.
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AFLP patterns can easily be collected in databases, and the
electronic fingerprinting data, generated by an automated se-
quencer, facilitate the transmission of results between different
laboratories. Nevertheless, standardization of protocols, re-
agents, and equipment is necessary before interlaboratory da-
tabases can be created. Due to the inevitable variation in lane
or background intensities, it is also useful to use an internal
reference strain to determine the cutoff value used for AFLP
type definition. The similarity level of 89% for internal ref-
erence strains is in agreement with earlier findings (5, 28).
Lindstedt et al. (21) suggested that variation in lane or back-
ground intensities might be due to differences in the effective-
ness of digestion-ligation or PCR amplification steps. It is also
worthwhile to ascertain visually that the banding patterns on
the gel are of uniform quality prior to numerical analysis.
In the evaluation of a typing system, several criteria must be
assessed. The most important of these are typeability, ease of
interpretation and performance, reproducibility, and discrimi-
natory power (23). The results of the present study indicate
that AFLP is a fast, reproducible, and highly discriminating
genotyping method with excellent typeability for characteriza-
tion of C. botulinum group I and II strains. These features
make AFLP an attractive alternative to other genotyping
methods in outbreak situations. In addition to typing at strain
level, AFLP may be a suitable tool for C. botulinum group
identification.
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